Loading chat...
IL SB2962
Bill
Status
1/27/2026
Primary Sponsor
Suzanne Glowiak Hilton
Click for details
AI Summary
-
Requires group and individual health insurance policies and managed care plans amended, issued, or renewed on or after January 1, 2028 to cover medically necessary epinephrine delivery systems
-
Expands the definition of "epinephrine injector" to include FDA-approved auto-injectors and pre-filled syringes with pre-measured doses equivalent to auto-injector dosages
-
Caps out-of-pocket costs for a twin-pack of epinephrine injectors or delivery systems at no more than $60, regardless of device type
-
Exempts high-deductible health plans from the cost cap requirement if compliance would disqualify the plan from health savings account eligibility under federal tax law
-
Amends Section 356z.33 of the Illinois Insurance Code, building on existing epinephrine injector coverage requirements for persons 18 and under
Legislative Description
INS-EPINEPHRINE DELIVERY SYS
Last Action
Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments
3/13/2026